Your browser doesn't support javascript.
loading
The management of the access tract after percutaneous nephrolithotomy.
Hüsch, Tanja; Reiter, Michael; Mager, René; Steiner, Eva; Herrmann, Thomas R W; Haferkamp, Axel; Schilling, David.
Afiliação
  • Hüsch T; Department of Urology and Paediatric Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Reiter M; Department of Urology and Paediatric Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Mager R; Department of Urology and Paediatric Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Steiner E; Department of Urology and Paediatric Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Herrmann TR; Department of Urology and Urologic Oncology, University Hospital Hannover, Hannover, Germany.
  • Haferkamp A; Department of Urology and Paediatric Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Schilling D; Department of Urology and Paediatric Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. David.Schilling@kgu.de.
World J Urol ; 33(12): 1921-8, 2015 Dec.
Article em En | MEDLINE | ID: mdl-25903804
ABSTRACT

PURPOSE:

To describe the evolution of the current technique in percutaneous nephrolithotomy (PCNL) with a special focus on access tract closure techniques.

METHODS:

A systematic review of outcomes and complications of tubeless PCNL was conducted using the MEDLINE and Pubmed databases between 1976 and 2014.

RESULTS:

During the past decade, PCNL underwent fundamental modifications due to miniaturization of the instruments and advancements in technique. The routine use of the nephrostomy tube after PCNL has been subsequently questioned. Currently, the nephrostomy tube is increasingly omitted, and the access tract is usually sealed by haemostatic agents. An additionally ureteric stent is commonly inserted at the end of the procedure. However, the application of haemostatic sealants increases the immediate costs significantly. Still there are inconsistent data because of small study populations, lack of randomization, retrospective character and further more heterogeneous surgical techniques.

CONCLUSION:

The current body of literature does not provide high-level evidence for the preferred treatment of the access tract in PCNL. However, most authors agree that a tract sealing can be omitted without increasing the risk of complication in uncomplicated procedures.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrostomia Percutânea / Hemostáticos / Técnicas de Fechamento de Ferimentos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrostomia Percutânea / Hemostáticos / Técnicas de Fechamento de Ferimentos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article